Cellectis S.A. (EPA:ALCLS)

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 257.55 million. The enterprise value is 255.26 million.

Market Cap	257.55M
Enterprise Value	255.26M

Important Dates

The last earnings date was Monday, May 11, 2026.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.59 million shares outstanding. The number of shares has increased by 2.78% in one year.

Current Share Class	72.59M
Shares Outstanding	72.59M
Shares Change (YoY)	+2.78%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	2.19%
Owned by Institutions (%)	16.74%
Float	46.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.95
PB Ratio	4.96
P/TBV Ratio	4.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.38
EV / Sales	3.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.38

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.54.

Current Ratio	1.52
Quick Ratio	0.35
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-19.12

Financial Efficiency

Return on equity (ROE) is -76.34% and return on invested capital (ROIC) is -18.35%.

Return on Equity (ROE)	-76.34%
Return on Assets (ROA)	-8.43%
Return on Invested Capital (ROIC)	-18.35%
Return on Capital Employed (ROCE)	-28.49%
Weighted Average Cost of Capital (WACC)	17.90%
Revenue Per Employee	286,981
Profits Per Employee	-256,866
Employee Count	229
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	-326,972
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +170.27% in the last 52 weeks. The beta is 2.72, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	2.72
52-Week Price Change	+170.27%
50-Day Moving Average	3.24
200-Day Moving Average	3.27
Relative Strength Index (RSI)	59.51
Average Volume (20 Days)	256,777

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 65.14 million and -58.31 million in losses. Loss per share was -0.58.

Revenue	65.14M
Gross Profit	65.14M
Operating Income	-38.22M
Pretax Income	-58.64M
Net Income	-58.31M
EBITDA	-28.74M
EBIT	-38.22M
Loss Per Share	-0.58

Balance Sheet

The company has 30.22 million in cash and 27.93 million in debt, with a net cash position of 2.29 million or 0.03 per share.

Cash & Cash Equivalents	30.22M
Total Debt	27.93M
Net Cash	2.29M
Net Cash Per Share	0.03
Equity (Book Value)	51.97M
Book Value Per Share	0.52
Working Capital	60.76M

Cash Flow

In the last 12 months, operating cash flow was -32.65 million and capital expenditures -1.93 million, giving a free cash flow of -34.59 million.

Operating Cash Flow	-32.65M
Capital Expenditures	-1.93M
Depreciation & Amortization	9.36M
Net Borrowing	-14.64M
Free Cash Flow	-34.59M
FCF Per Share	-0.48

Margins

Gross margin is 100.00%, with operating and profit margins of -58.66% and -89.51%.

Gross Margin	100.00%
Operating Margin	-58.66%
Pretax Margin	-90.01%
Profit Margin	-89.51%
EBITDA Margin	-44.11%
EBIT Margin	-58.66%
FCF Margin	n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.78%
Shareholder Yield	-2.78%
Earnings Yield	-22.64%
FCF Yield	-13.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2